vosevi 400mg100mg100mg tablets
gilead sciences international ltd - voxilaprevir; velpatasvir; sofosbuvir - tablet - 100mg ; 100mg ; 400mg
vosevi tablet
gilead sciences canada inc - sofosbuvir; velpatasvir; voxilaprevir - tablet - 400mg; 100mg; 100mg - sofosbuvir 400mg; velpatasvir 100mg; voxilaprevir 100mg - hcv polymerase inhibitors
vosevi
gilead sciences (nz) - sofosbuvir 400mg; ; ; ; velpatasvir 100mg; ; ; ; voxilaprevir 100mg; - film coated tablet - active: sofosbuvir 400mg velpatasvir 100mg voxilaprevir 100mg excipient: colloidal silicon dioxide copovidone croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose opadry beige 85f170040 - vosevi is indicated for the treatment of chronic hepatitis c virus (hcv) infection in adults.
epclusa tablet
gilead sciences canada inc - sofosbuvir; velpatasvir - tablet - 400mg; 100mg - sofosbuvir 400mg; velpatasvir 100mg - hcv polymerase inhibitors
epclusa 400mg100mg tablets
gilead sciences international ltd - sofosbuvir; velpatasvir - tablet - 400mg ; 100mg
epclusa
gilead sciences (nz) - sofosbuvir 400mg; ; ; ; velpatasvir 100mg; ; ; - tablet - 400mg/100mg - active: sofosbuvir 400mg velpatasvir 100mg excipient: copovidone croscarmellose sodium opadry ii pink 85f94644 magnesium stearate microcrystalline cellulose - indicated for the treatment of chronic hepatitis c virus (hcv) infection in adults.
velpanat tablets film-coated
natco pharma limited-pharma division - sofosbuvir, velpatasvir - tablets film-coated - 400mg+ 100mg
velsof tablets film-coated
m/s hetero labs ltd. - sofosbuvir, velpatasvir - tablets film-coated - 400mg+ 100mg
epclusa tablets film-coated
gilead sciences ireland uc - sofosbuvir, velpatasvir - tablets film-coated - 400mg+ 100mg
atavir 30 cap
cipla - atazanavir - cap - 300mg - 30